Source: MarketScreener

EnBiotix: Polyphor and EnBiotix announce closing of purchase agreement of Inhaled Murepavadin by EnBiotix

(marketscreener.com) EQS Group-Ad-hoc: Polyphor AG / Key word: Agreement Polyphor and EnBiotix announce closing of purchase agreement of Inhaled Murepavadin by EnBiotix 10-Sep-2021 / 07:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. ...https://www.marketscreener.com/quote/stock/POLYPHOR-AG-43371335/news/Polyphor-and-EnBiotix-announce-closing-of-purchase-agreement-of-Inhaled-Murepavadin-by-EnBiotix-36391307/?utm_medium=RSS&utm_content=20210910

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Jeffrey D. Wager's photo - Chairman & CEO of EnBiotix

Chairman & CEO

Jeffrey D. Wager

CEO Approval Rating

90/100

Read more